While clinical activity was evident across the entire patient population irrespective of PD-L1 status, there was a significant trend of improved response in patients with higher levels of PD-L1 expression.
← all excerpts
Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options.
1
—
—